| Date Filed | Type | Description |
| 07/18/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,250 shares
@ $6.5, valued at
$8.1k
Exercised 2,663 options to buy
@ $0 |
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,175 shares
@ $6.75, valued at
$7.9k
|
|
| 06/20/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,300 shares
@ $6.95, valued at
$9k
Exercised 2,664 options to buy
@ $0 |
|
| 06/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 3,380 shares
@ $7.38, valued at
$24.9k
Exercised 7,473 options to buy
@ $0 |
|
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,275 shares
@ $6.15, valued at
$7.8k
Exercised 2,663 options to buy
@ $0 |
|
| 05/02/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,100 shares
@ $6.15, valued at
$6.8k
|
|
| 05/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 04/17/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,320 shares
@ $6.48, valued at
$8.6k
Exercised 2,664 options to buy
@ $0 |
|
| 04/04/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/13/2017 |
3/A
| SBI Incubation Co., Ltd. (10% Owner) has filed a Form 3/A on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
3
| SBI Incubation Co., Ltd. (10% Owner) has filed a Form 3 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/02/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,250 shares
@ $7.72, valued at
$9.7k
|
|
| 03/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 3,550 shares
@ $7.7, valued at
$27.3k
Exercised 7,473 options to buy
@ $0 |
|
| 02/21/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 02/03/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,250 shares
@ $8.5, valued at
$10.6k
|
|
| 01/20/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 01/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,270 shares
@ $8.58, valued at
$10.9k
|
|
| 01/06/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 3,790 shares
@ $8.58, valued at
$32.5k
Exercised 7,473 options to buy
@ $0 |
|
| 12/27/2016 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 12/27/2016 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 12/19/2016 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,090 shares
@ $8.75, valued at
$9.5k
|
|
| 11/21/2016 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on ACUCELA INC. |
| 11/15/2016 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on ACUCELA INC. |
| 11/02/2016 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC. |
| 11/02/2016 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on ACUCELA INC.|
Txns:
| Paid exercise price by delivering 1,035 shares
@ $9.54, valued at
$9.9k
|
|
| 10/18/2016 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on ACUCELA INC. |
|